A detailed history of Black Rock Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Black Rock Inc. holds 162,561,081 shares of BMY stock, worth $6.68 Billion. This represents 0.21% of its overall portfolio holdings.

Number of Shares
162,561,081
Previous 168,103,766 3.3%
Holding current value
$6.68 Billion
Previous $8.63 Billion 2.21%
% of portfolio
0.21%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $266 Million - $302 Million
-5,542,685 Reduced 3.3%
162,561,081 $8.82 Billion
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $124 Million - $148 Million
-2,555,550 Reduced 1.5%
168,103,766 $8.63 Billion
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $117 Million - $130 Million
-2,013,059 Reduced 1.17%
170,659,316 $9.91 Billion
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $186 Million - $206 Million
-2,912,359 Reduced 1.66%
172,672,375 $11 Billion
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $188 Million - $213 Million
2,856,746 Added 1.65%
175,584,734 $12.2 Billion
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $87.3 Million - $103 Million
-1,274,864 Reduced 0.73%
172,727,988 $12.4 Billion
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $436,486 - $258 Million
3,357,590 Added 1.97%
174,002,852 $12.4 Billion
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $247 Million - $272 Million
3,404,834 Added 2.04%
170,645,262 $13.1 Billion
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $122 Million - $146 Million
-1,986,279 Reduced 1.17%
167,240,428 $12.2 Billion
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $392 Million - $457 Million
-7,307,256 Reduced 4.14%
169,226,707 $10.6 Billion
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $84.8 Million - $99.3 Million
1,433,256 Added 0.82%
176,533,963 $10.4 Billion
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $10.8 Billion - $11.8 Billion
175,100,707 New
175,100,707 $11.7 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $87.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.